Abstract:Objective: This study aims to investigate the effect of nimodipine combined with betahistine on the levels of CRP and other inflammatory cytokines, as well as vascular endothelial function in patients with hypertensive cerebral vasospasm. Methods: A total of 80 patients with hypertensive cerebral vasospasm from March 2016 to September 2018 were enrolled and randomly equally divided into two groups. At 1 week before enrollment, the application of all antihypertensive drugs was stopped. Then amlodipine tablets were used in control group, based on which nimodipine tablets were applied in observation group. All the patients included were followed up for 1 month. The changes in the cerebral vasospasm index in the course of treatment as well as inflammatory cytokines and indicators related to vascular endothelial function at 1 month after treatment were measured and compared between the two groups. The correlations of the cerebral vasospasm index with the changes in inflammatory cytokines and vascular endothelial function-related factors in the body were analyzed. Finally, the effective rates of blood pressure regulation and cerebral vasospasm treatment were compared, while the adverse reactions and the overall clinical treatment effect of the two groups were evaluated. Results: The cerebral vasospasm indexes in observation group were significantly lower than those in control group at 3 d, 1 week and 1 month after treatment (p < 0.05). At 1 month after treatment, the levels of inflammatory cytokines such as high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in observation group were significantly reduced compared to those in control group (p < 0.05). As for vascular endothelial function-related indicators, the endothelin-1 (ET-1) level in observation group was markedly lower than that in control group, whereas the level of nitric oxide (NO) was statistically higher than that in control group (p < 0.05). The cerebral vasospasm index was statistically positively correlated with changes in hs-CRP, IL-6, TNF-α and ET-1 (p < 0.05), but negatively correlated with changes in NO (p < 0.05). Besides, the effective rates of blood pressure regulation and cerebral vasospasm treatment in observation group were significantly higher than those in control group (p < 0.05). The overall treatment effective rate in observation group was markedly higher than that in control group (p < 0.05), and there were no significant differences of adverse reactions between the two groups (p > 0.05). Conclusion: For the treatment of hypertensive cerebral vasospasm, combined application of betahistine on the basis of nimodipine can effectively reduce the body's aseptic inflammatory responses, improve vascular endothelial function and increase the cerebral circulation blood flow, which offers a favorable strategy for clinical therapy.

Clinical effect analysis of propofol combined with nicardipine in reducing cerebral vasospasm caused by neurointerventional therapy

Effect of Xingnaojing Injection on nitric oxide, insulin-like growth factor-1 and macrophage inhibitory factor of hypertensive patients with intracerebral hemorrhage

Propofol Pretreatment Attenuates Aquaporin-4 Over-Expression and Alleviates Cerebral Edema after Transient Focal Brain Ischemia Reperfusion in Rats

Clinical Observation of Target-Controlled Infusion of Propofol During Anesthesia Induction in Intracranial Aneurysms Interventional Treatment

Evaluating Effect of Esmolol Combined with Nitroglycerin During Induced Hypotension on Hypertension Patients in Spinal Surgery

Effects of low-dose propofol on inflammatory cytokines in patients undergoing selective coronary angiography

Effects of nimodipine combined with betahistine on CRP and other inflammatory cytokines and vascular endothelial function in patients with hypertensive cerebral vasospasm

Effect observation of nimodipine combined with atorvastatin in the prevention of cerebral vasospasm after subarachnoid hemorrhage and effect on ET-1 and NO

Effects of Propofol on Serum-Related Cytokines for Patients with Spinal Injury in Perioperative Period

[Effect of Propofol on the Activation of Nuclear Factor-Kappa B and Expression of Inflammatory Cytokines in Cerebral Cortex During Transient Focal Cerebral Ischemia-Reperfusion: Experiment with Rats].

Effect of propofol on expressions of TNF-α,IL-10 and NF-κB in rat cerebrum undergoing ischemia and reperfusion

A Comparison of the Effects of Prolonged Infusion of Propofol 2% and 1% During Total Intravenous Anaesthesia Using Target-Controlled Infusion Technique for Elective Neurosurgery

Effect of Interventional Therapy on IL-1β, IL-6, and Neutrophil-Lymphocyte Ratio (NLR) Levels and Outcomes in Patients with Ischemic Cerebrovascular Disease

Effects of esmolol, or nicardipine combined with volume expansion on propofol dosage during total intravenous anesthesia

The effects of combination of nicardipine-induced hypotension with moderate hypervolemic hemodilution on the visceral oxygenation and systemic inflammatory responses

Clinical study of controlled hypotension induced with combination of propofol and desflurane in neurosurgical procedure

Effect of nimodipine combined with atorvastatin calcium on microinflammation and oxidative stress levels in patients with cerebral vasospasm after subarachnoid hemorrhage

Analysis of Curative Effect and Prognosis of Intracranial Vascular Interventional Therapy for Ischemic Cerebrovascular Disease

Comparing controlled hypotension effects of nicardipine used in two different ways in spinal tumoroperation

Effect of controlled hypotension induced of nicardipine on cerebral regional oxygen saturation during transsphenoidal pituitary tumor resection

Protective Effect of the General Anesthetic: Propofol on the Intracranial Hemorrhage